# Study in Chronic Kidney Disease (CKD) Not on Dialysis

> **NCT01110629** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 143 (actual)

## Conditions studied

- Hyperphosphatemia

## Interventions

- **DRUG:** Fosrenol (Lanthanum Carbonate, BAY77-1931)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01110629
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2014-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01110629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01110629, "Study in Chronic Kidney Disease (CKD) Not on Dialysis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01110629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*